We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$321M
AUM Growth
-$12M
Cap. Flow
+$1.48M
Cap. Flow %
0.46%
Top 10 Hldgs %
72.64%
Holding
50
New
7
Increased
14
Reduced
7
Closed
11

Top Buys

Rank Stock Value
1
SIMO icon
Silicon Motion
SIMO
+$21.5M
2
ARQ icon
Arq
ARQ
+$14.8M
3
INFN
Infinera Corporation Common Stock
INFN
+$13.1M
4
ELUT icon
Elutia
ELUT
+$4.1M
5
BDSX icon
Biodesix
BDSX
+$3.51M

Top Sells

Rank Stock Value
1
OUST icon
Ouster
OUST
+$14.7M
2
HUMA icon
Humacyte
HUMA
+$6.71M
3
FENC icon
Fennec Pharmaceuticals
FENC
+$6.34M
4
ALIM
Alimera Sciences
ALIM
+$5.93M
5
OSPN icon
OneSpan
OSPN
+$5.82M

Sector Composition

Rank Sector Weight
1 Healthcare 35.92%
2 Technology 20.02%
3 Industrials 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
$92.7M 28.88%
1,000,000
– –
WDC icon
2
CALL
Western Digital
WDC
$166B
$22.7M 7.08%
+396,900
New +$22M
SIMO icon
3
Silicon Motion
SIMO
$7.14B
$22.3M 6.94%
+275,000
New +$21.5M
INFN
4
DELISTED
Infinera Corporation Common Stock
INFN
$20.5M 6.39%
3,368,556
+2,479,272
+279% +$13.1M
DCTH icon
5
Delcath Systems
DCTH
$400M
$20.1M 6.26%
2,399,792
+40,064
+2% +$254K
SCPH
6
DELISTED
scPharmaceuticals
SCPH
$15.2M 4.75%
3,504,365
+115,206
+3% +$506K
ARQ icon
7
Arq
ARQ
$82.4M
$13M 4.05%
+2,142,078
New +$14.8M
MYO icon
8
Myomo
MYO
$36.5M
$9.37M 2.92%
2,917,997
+115,405
+4% +$391K
BDSX icon
9
Biodesix
BDSX
$216M
$8.84M 2.75%
288,991
+122,937
+74% +$3.51M
ELUT icon
10
Elutia
ELUT
$39.8M
$8.42M 2.62%
1,697,316
+1,260,750
+289% +$4.1M
TELA icon
11
TELA Bio
TELA
$30.2M
$7.79M 2.43%
1,656,655
+241,400
+17% +$1.27M
CLRB icon
12
Cellectar Biosciences
CLRB
$20.2M
$6.86M 2.14%
101,206
+7,709
+8% +$740K
EGRX
13
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$6.78M 2.11%
1,211,509
+25,000
+2% +$109K
ELVA
14
Electrovaya
ELVA
$382M
$6.64M 2.07%
2,575,428
-1,544,513
-37% -$4.69M
IDN icon
15
Intellicheck
IDN
$74.7M
$6.05M 1.88%
1,767,732
+253,706
+17% +$829K
RCAT icon
16
Red Cat Holdings
RCAT
$1.05B
$5.66M 1.76%
4,920,601
-44,272
-0.9% -$47.7K
PROF
17
Profound Medical
PROF
$266M
$5.44M 1.69%
646,733
– –
THTX
18
DELISTED
Theratechnologies
THTX
$5.23M 1.63%
3,725,204
– –
IPWR icon
19
Ideal Power
IPWR
$56M
$4.94M 1.54%
700,000
– –
LPTH icon
20
Lightpath Technologies
LPTH
$594M
$4.69M 1.46%
3,723,932
+200,000
+6% +$272K
COYA icon
21
Coya Therapeutics
COYA
$93.8M
$3.94M 1.23%
649,427
– –
BKTI icon
22
BK Technologies
BKTI
$294M
$3.62M 1.13%
282,772
-48,124
-15% -$657K
IMMX icon
23
Immix Biopharma
IMMX
$590M
$2.79M 0.87%
1,406,680
-148,320
-10% -$341K
APRE icon
24
Aprea Therapeutics
APRE
$7.51M
$2.19M 0.68%
539,300
– –
PYPD icon
25
PolyPid
PYPD
$77.3M
$2.05M 0.64%
479,246
– –
1
2

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $732M AUM 28.13% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

AIGH Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, AIGH Capital Management held 50 positions worth $321M, down 3.6% from $333M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

AIGH Capital Management's Q2 2024 filing shows 7 new, 14 increased, 7 reduced and 11 closed positions. Its largest new stake was Silicon Motion: 275,000 shares worth $22.3M. The largest sale was Ouster, an estimated $14.7M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 42% a quarter earlier, followed by Technology and Industrials.

  • AIGH Capital Management's largest Q2 2024 buy was Silicon Motion: 275,000 shares worth $22.3M.
  • AIGH Capital Management added most to Infinera Corporation Common Stock in Q2 2024, an estimated $13.1M increase.
  • AIGH Capital Management's biggest Q2 2024 reduction was Electrovaya, cutting an estimated $4.69M.
  • AIGH Capital Management fully exited Ouster in Q2 2024, selling an estimated $14.7M.
  • AIGH Capital Management's ten largest holdings make up 73% of its $321M portfolio in Q2 2024.
  • AIGH Capital Management opened 7 new positions and closed 11 in Q2 2024.
  • AIGH Capital Management's portfolio value fell 3.6% quarter-over-quarter to $321M.

Based on AIGH Capital Management's 13F filing for Q2 2024, filed 7 Aug 2024.